SMART BIOMARKERS
Successful clinical trials with smart biomarkers
Abzu's smart biomarkers
Discover and design composite biomarkers for diagnosis, patient stratification and response monitoring.
Flexible services to support your team
Data access + data processing
We enhance your research with biobank access and prepare your raw data for analysis.
High-performing + interpretable results
Review a set of composite biomarker signatures with clear and explainable model interpretations.
Regulatory compliance + approval
Confidently nominate your signature with our comprehensive report and GCP-certified support.
Why Abzu?
If we want to understand the world we live in, then we need to explain phenomena instead of reacting to black-box predictions from traditional machine learning technologies.
What people are saying
Working with Abzu and using the QLattice to analyze our clinical data has provided us with new insights and helped us generate new hypotheses for exploring the potential for a biomarker-based enrichment strategy across cancer.
Collaborating with Abzu has led to highly significant new knowledge. Using the QLattice in combination with biomarkers as well as medical and social register data is a very promising approach to personalised medicine.
Hypotheses generated by Abzu's explainable AI QLattice technology are brilliantly put into context with our knowledge graphs. I believe a combined setup like ours is a very realistic picture of the future of data science.
Collaborating with Abzu helped identify quantifiable key drivers that led to discovering the key biomarkers involved with SARS-CoV-2 infection. Abzu was able to enrich our understanding and produce novel analyses.
Case studies
publication
Elyse Sims
November 30, 2022
publication
Journal of Gastroenterology and Hepatology
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach
Elyse Sims
October 13, 2022
event
Intelligent Health AI
The world’s leading AI-in-medicine summit series. Connecting 200,000 clinicians, technologists, and C-suite executives.
Sam Demharter
September 8, 2022
Contact Abzu
We’re just a bunch of nice nerds building something new and awesome. How can we help you?
